Progressive multifocal leukoencephalopathy after first-line radiotherapy and temozolomide for glioblastoma

Neuro Oncol. 2022 Mar 12;24(3):497-498. doi: 10.1093/neuonc/noab306.
No abstract available

Publication types

  • Letter

MeSH terms

  • Brain Neoplasms* / drug therapy
  • Brain Neoplasms* / radiotherapy
  • Glioblastoma* / drug therapy
  • Glioblastoma* / radiotherapy
  • Humans
  • Leukoencephalopathy, Progressive Multifocal* / chemically induced
  • Temozolomide / adverse effects

Substances

  • Temozolomide